The rating assignment incorporates several factors, including Orlando Health’s second year of improved financial performance.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Orlando Health will continue its strong financial performance in fiscal years 2016 and 2017.
Moody’s also upgraded Orlando Health’s outstanding ratings to “A2” from “A3,” affecting approximately $796 million.
More articles on healthcare finance:
LogixHealth breaks down ICD-10 code changes: 6 quick facts
Regulators approve closure of Illinois hospital
BayCare operating income climbs 7% while bottom line falls
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
